Send to

Choose Destination
J Clin Rheumatol. 1997 Jun;3(3):158-61.

Lymphocytic vasculitis presenting as diffuse subcutaneous edema after hepatitis B virus vaccine.

Author information

Department of Rheumatic and Immunologic Diseases (Y.D., L.H.C.) and Department of Pathology (R.A.P.), The Cleveland Clinic Foundation, Cleveland, Ohio; and Department of Pathology (A.B.), Georgetown University Medical Center, Washington, District of Columbia.


We report a case of a previously healthy 26-year-old female who developed severe persistent swelling of the subcutaneous tissues after immunization with hepatitis B vaccine. Ultimately, the patient was found to have a lymphocytic vasculitis of the muscle, and the vasculitis responded completely to corticosteroids. Detailed immunopathologic analysis revealed the infiltrate to be composed of nonmonoclonal activated CD4-positive T cells.The case is instructive for the following reasons: a) Hepatitis B vaccine is now widely indicated. Although generally safe, it is associated with a variety of rheumatic conditions and may rarely trigger vasculitis. Immunization history is important in evaluating patients with rheumatologic symptoms. b) Diffuse subcutaneous edema/capillary leak is an unusual presentation of vasculitis and may be the result of interleukin 2 secretion by activated lymphocytes.

Supplemental Content

Loading ...
Support Center